中华医学杂志（英文版）2009，Vol.122Issue(6)：659-664,6.DOI:10.3760/cma.j.issn.0366-6999.2009.06.013
Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome
Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome
JIA Xin-wei 1FU Xiang-hua 1ZHANG Jing 1GU Xin-shun 1FAN Wei-ze 1WU Wei-li 1HAO Guo-zhen 1LI Shi-qiang 1JIANG Yun-fa1
作者信息
- 1. Department of Cardiovascular Disease, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China
- 折叠
摘要
Abstract
Background The incidence of no reflow phenomenon limits the clinical outcomes of percutaneous coronary intervention (PCI). This randomized controlled study was designed to evaluate the immediate protective effects of intensive stalin pretreatment on myocardial perfusion and myocardial ischemic injury during PCI.Methods Altogether 228 patients with acute coronary syndrome (ACS) were randomly assigned to standard stalin group (SS group, n=115) and intensive statin group (IS group, n=113). Patients in the SS group received 20 mg simvastatin and patients in the IS group received 80 mg simvastatin for 7 days before PCI. Thrombolysis in myocardial infarction (TIMI) flow grade (TFG), corrected TIMI frame count (CTFC) and TIMI myocardial perfusion grade (TMPG) of the intervened vessel were recorded before and after stent deployment. Creatine kinase (CK) isoenzyme MB, troponin I and plasma level of high sensitive-C reactive protein (hs-CRP), P-selectin and intercellular adhesion molecule (ICAM) were measured before and 24 hours after the procedure.Results The TFG after stent deployment was significantly improved with less TIMI 0-1 and more TIMI 3 blood flow in the IS group than in the SS group (all P<0.05). Patients with no reflow phenomenon were less in the IS group (P<0.001). The CTFC was lower in the IS group than in the SS group (P<0.001). TMPG was also improved in the IS group than in the SS group (P=0.001). Although PCI caused a significant increase in CK-MB 24 hours after the procedure, the elevated CK-MB value was lower in the IS group than in the SS group (18.74±8.41 vs 21.78±10.64, P=0.018). Similar changes were also found in troponin I (0.99±1.07 in the IS group vs 1.47±1.54 in the SS group, P=0.006). CK-MB elevation occurred in 27.8% (32/115) of the patients in the SS group vs 15.9% (18/113) in the IS group (P=0.030). Myocardial necrosis was detected in 4.4% (5/115) of the patients in the SS group, whereas 0.9% (1/113) in the IS group (P=0.341). But no myocardial infarction was found. Similarly, the patients with increased level of troponin I were much more in the SS group (36.5%, 42/115) than in the IS group (19.5%, 22/113) (P=0.04). Among them, myocardial necrosis was detected in 13.0% (15/115) of the patients in the SS group, while 4.4% (5/113) in the IS group (P=0.021). Myocardial infarction was found in 4.4% (5/115) of the patients in the SS group and 0.9% (1/113) in the IS group (P=0.213).Conclusions Intensive statin pretreatment for 7 days before PCI can further improve myocardial blood perrusion, protect the myocardium from ischemic injury. These effects are associated with the lowered levels of hs-CRP, P-selectin and ICAM.关键词
simvastatin/myocardium/perfusion/percutaneous coronary intervention/acute coronary syndrome/no reflow phenomenonKey words
simvastatin/myocardium/perfusion/percutaneous coronary intervention/acute coronary syndrome/no reflow phenomenon分类
医药卫生引用本文复制引用
JIA Xin-wei,FU Xiang-hua,ZHANG Jing,GU Xin-shun,FAN Wei-ze,WU Wei-li,HAO Guo-zhen,LI Shi-qiang,JIANG Yun-fa..Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome[J].中华医学杂志（英文版）,2009,122(6):659-664,6.
